Active	Status	Sponsor type	Region	Phase	Filter
29 Active 12 Inactive 41 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wolfe, Robert R
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy	Completed	2	190	Canada, US	SUVN-G3031, Samelisant, Placebo	Suven Life Sciences Limited	Narcolepsy	06/23	06/23
Ryan, Elizabeth
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection	Recruiting	1/2	72	US, RoW	RSP-1502, Tobramycin inhalation solution	Respirion Pharmaceuticals Pty Ltd	Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa	12/25	12/25
Ong, Shirley
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study) Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma	Recruiting	3	450	Europe, Canada, Japan, US, RoW	Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo	Chimerix	H3 K27M, Glioma	08/26	08/26
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme Jan 2023 - Jun 2023 : Data from trial for glioblastoma Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults	Active, not recruiting	2	210	Europe, US	Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine	CNS Pharmaceuticals, Inc., Worldwide Clinical Trials	Glioblastoma Multiforme, Adult	12/24	03/25
ReSPECT-LM, NCT05034497: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases	Recruiting	1	18	US	186RNL, Rhenium-186 NanoLiposome	Plus Therapeutics	Leptomeningeal Metastasis	12/25	06/26
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221	Available	N/A		US	DCVax-L	Northwest Biotherapeutics	GBM, Glioblastoma Multiforme
Johnson, Larry G
BMX-04-001, NCT05010577 / 2022-003810-35: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection	Active, not recruiting	1b/2a	32	Europe, US, RoW	BX004-A, Bacteriophage, Placebo, Vehicle buffer	BiomX, Inc., BiomX Ltd.	Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis	10/23	03/24
NCT06052293: Phase 1 Study to Assess Safety and Efficacy of ANG003	Completed	1	51	US	ANG003, Dose Level 1, Dose Level 2, Dose Level 3, and Dose Level 4.	Anagram Therapeutics, Inc.	Exocrine Pancreatic Insufficiency	07/24	07/24
Petersen, Erika
VISION, NCT05774041: Visualization of the STN and GPi for DBS	Recruiting	N/A	90	US	SIS System	Surgical Information Sciences Inc.	Deep Brain Stimulation, Parkinson Disease	02/25	08/25
NCT04246281: The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain	Active, not recruiting	N/A	230	US	SPRINT Peripheral Nerve Stimulation (PNS) System, Standard interventional management of low back pain	SPR Therapeutics, Inc., United States Department of Defense	Low Back Pain, Back Pain	03/26	02/27
Keyes, Alperdis L
SARCA, NCT05339139: SAfety of Regional Citrate Anticoagulation ( Study)	Recruiting	3	50	US	Dialysis	Fresenius Medical Care North America	Acute Kidney Injury, ESRD	11/24	03/25
Muller, Geoffrey
No trials found